James Edgemond - 22 Jun 2026 Form 4 Insider Report for UNITED THERAPEUTICS Corp (UTHR)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
23 Jun 2026, 16:34:21 UTC
Prior SEC filing
22 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ John S. Hess, Jr. under Power of Attorney

Key filing fact

James Edgemond filed Form 4 for UNITED THERAPEUTICS Corp (UTHR) on 23 Jun 2026.

Key facts

  • This page summarizes James Edgemond's Form 4 filing for UNITED THERAPEUTICS Corp (UTHR).
  • 10 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 23 Jun 2026, 16:34.

Change

  • Previous filing in this sequence was filed on 22 Jun 2026.
  • Current net transaction value: -$4,708,786.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001636178 Primary reporting owner

EDGEMOND JAMES

Relationship
CFO AND TREASURER
Address
C/O UNITED THERAPEUTICS CORPORATION, 1000 SPRING STREET, SILVER SPRING
Signature
/s/ John S. Hess, Jr. under Power of Attorney
Signature date
23 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

UTHR transaction

Common Stock

Options Exercise

Transaction value
Shares
+8,750
Change %
+46%
Price
$146.03*
Shares after
27,626
Date
22 Jun 2026
Ownership
Direct
Footnotes
F1
UTHR transaction

Common Stock

Sale

Transaction value
$87,586
Shares
-164
Change %
-0.59%
Price
$534.06
Shares after
27,462
Date
22 Jun 2026
Ownership
Direct
Footnotes
F1, F2
UTHR transaction

Common Stock

Sale

Transaction value
$462,762
Shares
-865
Change %
-3.1%
Price
$534.98
Shares after
26,597
Date
22 Jun 2026
Ownership
Direct
Footnotes
F1, F3
UTHR transaction

Common Stock

Sale

Transaction value
$584,827
Shares
-1,091
Change %
-4.1%
Price
$536.05
Shares after
25,506
Date
22 Jun 2026
Ownership
Direct
Footnotes
F1, F4
UTHR transaction

Common Stock

Sale

Transaction value
$451,234
Shares
-840
Change %
-3.3%
Price
$537.18
Shares after
24,666
Date
22 Jun 2026
Ownership
Direct
Footnotes
F1, F5
UTHR transaction

Common Stock

Sale

Transaction value
$1,219,638
Shares
-2,266
Change %
-9.2%
Price
$538.23
Shares after
22,400
Date
22 Jun 2026
Ownership
Direct
Footnotes
F1, F6
UTHR transaction

Common Stock

Sale

Transaction value
$1,075,025
Shares
-1,994
Change %
-8.9%
Price
$539.13
Shares after
20,406
Date
22 Jun 2026
Ownership
Direct
Footnotes
F1, F7
UTHR transaction

Common Stock

Sale

Transaction value
$151,151
Shares
-280
Change %
-1.4%
Price
$539.83
Shares after
20,126
Date
22 Jun 2026
Ownership
Direct
Footnotes
F1, F8
UTHR transaction

Common Stock

Sale

Transaction value
$676,562
Shares
-1,250
Change %
-6.2%
Price
$541.25
Shares after
18,876
Date
22 Jun 2026
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

UTHR transaction Derivative

Stock Option

Options Exercise

Transaction value
Shares
-8,750
Change %
-100%
Price
$0.000000*
Shares after
0
Date
22 Jun 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
8,750
Exercise price
$146.03
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 8 footnotes

Footnote F1

This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025.

Footnote F2

This transaction was executed in multiple trades at prices ranging from $533.57 to $534.53. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Footnote F3

This transaction was executed in multiple trades at prices ranging from $534.57 to $535.56. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Footnote F4

This transaction was executed in multiple trades at prices ranging from $535.64 to $536.47. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Footnote F5

This transaction was executed in multiple trades at prices ranging from $536.65 to $537.59. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Footnote F6

This transaction was executed in multiple trades at prices ranging from $537.67 to $538.66. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Footnote F7

This transaction was executed in multiple trades at prices ranging from $538.67 to $539.66. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Footnote F8

This transaction was executed in multiple trades at prices ranging from $539.68 to $539.92. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .